HASI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HASI is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has positive long-term growth potential as indicated by analyst ratings and a strong pipeline, the recent financial performance is weak, and technical indicators do not suggest an immediate upward trend. The lack of recent news or significant trading signals further supports a hold recommendation.
The technical indicators for HASI are mixed. The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 42.952, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 35.674) but below the pivot (36.72), suggesting limited immediate upside potential.
Analyst ratings are consistently positive, with multiple firms raising price targets and maintaining buy or outperform ratings. The company's long-term pipeline has grown to over $6.5B, and the 10% EPS CAGR guidance through 2028 underscores strong growth potential. Hedge funds have significantly increased their buying activity, which is a positive signal.
The company's Q4 financial performance showed a significant decline in net income (-174.11% YoY) and EPS (-173.08% YoY), with gross margin also dropping by 14.94%. These financial weaknesses could weigh on the stock's performance in the near term. Additionally, technical indicators do not suggest a strong upward trend, and there is no recent news or congress trading activity to act as a catalyst.
In Q4 2025, revenue increased by 13.34% YoY to $114.81M, but net income dropped significantly to -$51.65M, a decline of -174.11% YoY. EPS also fell to -0.38, down -173.08% YoY. Gross margin decreased to 33.37%, down 14.94% YoY. While revenue growth is promising, the sharp decline in profitability is a concern.
Analysts are bullish on HASI, with multiple firms raising price targets recently. The updated price targets range from $38 to $50, with most firms maintaining buy or outperform ratings. Analysts highlight the company's strong pipeline, capital efficiency improvements, and long-term EPS growth guidance as key positives.
